NervGen Pharma's total assets for Q1 2025 were C$15.84M, a decrease of -18.72% from the previous quarter. TSE:NGEN total liabilities were C$14.45M for the fiscal quarter, a -14.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.